Segui
Vincenzo Calderone
Vincenzo Calderone
Professore Ordinario di Farmacologia, UniversitÓ di Pisa
Email verificata su farm.unipi.it
Titolo
Citata da
Citata da
Anno
Cardiovascular effects of Urtica dioica L.(Urticaceae) roots extracts: in vitro and in vivo pharmacological studies
L Testai, S Chericoni, V Calderone, G Nencioni, P Nieri, I Morelli, ...
Journal of Ethnopharmacology 81 (1), 105-109, 2002
2272002
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels
V Calderone, S Chericoni, C Martinelli, L Testai, A Nardi, I Morelli, ...
Naunyn-Schmiedeberg's archives of pharmacology 370, 290-298, 2004
1932004
Hydrogen sulphide: novel opportunity for drug discovery
A Martelli, L Testai, MC Breschi, C Blandizzi, A Virdis, S Taddei, ...
Medicinal research reviews 32 (6), 1093-1130, 2012
1792012
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo
A Martelli, L Testai, V Citi, A Marino, I Pugliesi, E Barresi, G Nesi, ...
ACS medicinal chemistry letters 4 (10), 904-908, 2013
1562013
Large-conductance, Ca2+-activated K+ channels: function, pharmacology and drugs
V Calderone
Current medicinal chemistry 9 (14), 1385-1395, 2002
1522002
(+/−)‐Naringenin as large conductance Ca2+‐activated K+ (BKCa) channel opener in vascular smooth muscle cells
S Saponara, L Testai, D Iozzi, E Martinotti, A Martelli, S Chericoni, ...
British journal of pharmacology 149 (8), 1013-1021, 2006
1442006
Nutraceutical value of citrus flavanones and their implications in cardiovascular disease
L Testai, V Calderone
Nutrients 9 (5), 502, 2017
1292017
Synthesis and β-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano [2, 3-b] pyridine: Potential antihypertensive agentsá…
PL Ferrarini, C Mori, M Badawneh, V Calderone, R Greco, C Manera, ...
European journal of medicinal chemistry 35 (9), 815-826, 2000
1292000
Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels
A Martelli, L Testai, MC Breschi, K Lawson, NG McKay, F Miceli, ...
Pharmacological research 70 (1), 27-34, 2013
1272013
Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts
L Testai, A Martelli, M Cristofaro, MC Breschi, V Calderone
Journal of Pharmacy and Pharmacology 65 (5), 750-756, 2013
1132013
Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition
M Bucci, V Vellecco, A Cantalupo, V Brancaleone, Z Zhou, S Evangelista, ...
Cardiovascular research 102 (1), 138-147, 2014
1032014
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels
LDC Mannelli, E Lucarini, L Micheli, I Mosca, P Ambrosino, MV Soldovieri, ...
Neuropharmacology 121, 49-59, 2017
1012017
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?
V Citi, A Martelli, L Testai, A Marino, MC Breschi, V Calderone
Planta medica 80 (08/09), 610-613, 2014
982014
Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?
A Martelli, L Testai, V Citi, A Marino, FG Bellagambi, S Ghimenti, ...
Vascular pharmacology 60 (1), 32-41, 2014
972014
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury
L Testai, A Martelli, A Marino, V D’antongiovanni, F Ciregia, L Giusti, ...
Biochemical pharmacology 85 (11), 1634-1643, 2013
962013
Proposal of a new binding orientation for non-peptide AT1 antagonists: Homology modeling, docking and three-dimensional quantitative structure− activity relationship analysis
T Tuccinardi, V Calderone, S Rapposelli, A Martinelli
Journal of medicinal chemistry 49 (14), 4305-4316, 2006
892006
Mitochondrial potassium channels as pharmacological target for cardioprotective drugs
L Testai, S Rapposelli, A Martelli, MC Breschi, V Calderone
Medicinal Research Reviews 35 (3), 520-553, 2015
832015
Synthesis of 1, 8-naphthyridine derivatives: Potential antihypertensive agents—Part VII
PL Ferrarini, C Mori, M Badawneh, V Calderone, L Calzolari, T Loffredo, ...
European journal of medicinal chemistry 33 (5), 383-397, 1998
811998
New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties
MC Breschi, V Calderone, M Digiacomo, M Macchia, A Martelli, ...
Journal of medicinal chemistry 49 (8), 2628-2639, 2006
762006
1, 5-Diarylsubstituted 1, 2, 3-triazoles as potassium channel activators. VI
G Biagi, V Calderone, I Giorgi, O Livi, E Martinotti, A Martelli, A Nardi
Il Farmaco 59 (5), 397-404, 2004
762004
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20